510(k) device
Dayspring
Koya Medical, Inc. · Sleeve, Limb, Compressible (JOW, Class II) · First FDA decision Apr 23, 2021, newest Jan 4, 2024LymphedemaPulmonary embolism and deep vein thrombosis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
6
Naming "Dayspring"
MAUDE reports
1
Brand "Dayspring", since 2015
PubMed studies
2
Mentioning "Dayspring"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dayspring
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Dayspring510(k)
K223228 · Decided Jan 4, 2024 · 443 days after receipt
Device type: Sleeve, Limb, Compressible (JOW) · Cardiology
- Dayspring510(k)
K210885 · Decided Apr 23, 2021 · 29 days after receipt
Device type: Sleeve, Limb, Compressible (JOW) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Dayspring", any status and sponsor, newest update first.
Koya Medical, Inc.Not on our public-company list
NCT06418282 · 100 participants (planned) · Start May 13, 2024 · Primary completion Dec 31, 2027
Device: Dayspring · For: Phlebolymphedema; Lymphedema; Chronic Venous Insufficiency
Sites: New York, New York
Koya Medical, Inc.Not on our public-company list
NCT04897035 · 24 participants · Start Jun 1, 2021 · Primary completion Jun 30, 2022
Device: Dayspring Active Wearable Compression System · For: Lymphedema; Lymphedema Lower Extremity; Chronic Venous Insufficiency and 1 more
Sites: Los Altos, California; Morgan Hill, California
- A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity LymphedemaPivotal-lookingCompleted
Koya Medical, Inc.Not on our public-company list
NCT05507346 · 121 participants · Start Sep 6, 2022 · Primary completion Jan 9, 2024
Device: Cross over Device (PCD or Dayspring - alternate to first group) · For: Lymphedema; Lymphedema of Leg; Chronic Venous Insufficiency and 2 more
Sites: Oakland, California
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Dayspring", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code JOW
1,052 reports: 868 malfunction, 177 injury, 4 death
Newest reports for this brand
- DAYSPRINGInjury
3033981998-2026-00001 · Received May 12, 2026 · Event dated Apr 14, 2026
Device type: Sleeve, Limb, Compressible (JOW)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Impaired Healing; Peripheral Edema
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Dayspring"[tiab]. The summary above synthesizes these.
- Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, an Open-Label Controlled Study.
Rockson SG, Karaca-Mandic P, Skoracki R, et al. · Lymphat Res Biol · 2022Research Support, Non-U.S. Gov't
- Results from a comparative study to evaluate the treatment effectiveness of a nonpneumatic compression device vs an advanced pneumatic compression device for lower extremity lymphedema swelling (TEAYS study).
Barfield M, Winokur R, Berland T, et al. · J Vasc Surg Venous Lymphat Disord · 2025Randomized Controlled Trial, Comparative Study
Other devices of this type
Also filed under product code JOW.
- Hygia Health Services Reprocessed Compression Sleeves / Foot CuffsHygia Health Services, Inc. · 510(k) 2009
- Reprocessed Compression SleevesAlliance Medical Corp. · 510(k) 2006
- Lympha Press Optimal PlusMego Afek AC , Ltd. · 510(k) 2019
- Reprocessed Kendall SCD Express Compression SleevesCovidien · 510(k) 2017
- Kendall Scd 700 Sequential Compression ControllerCovidien · 510(k) 2013
- Vasculaire Compression SystemVenous Health Systems, Inc. · 510(k) 2013
- Aircast Venaflow Elite SystemDjo, LLC · 510(k) 2013
- medi pneumatic compression system (pcs)-genius (Model 652)Medi USA, LP · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.